TI
GSK icon

Tidal Investments’s GSK GSK Stock Holding History

Tidal Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
210,633
+162,332
+336% +$8.8M 0.02% 516
2025
Q4 		$2.37M Buy
48,301
+7,393
+18% +$345K 0.01% 896
2025
Q3 		$1.77M Buy
40,908
+486
+1% +$19K ﹤0.01% 961
2025
Q2 		$1.55M Buy
40,422
+8,113
+25% +$310K 0.01% 833
2025
Q1 		$1.25M Buy
32,309
+1,294
+4% +$47.4K 0.01% 883
2024
Q4 		$1.05M Buy
31,015
+1,823
+6% +$65.6K 0.01% 982
2024
Q3 		$1.19M Sell
29,192
-969
-3% -$39.6K 0.01% 909
2024
Q2 		$1.16M Buy
30,161
+2,826
+10% +$119K 0.02% 810
2024
Q1 		$1.17M Buy
27,335
+1,715
+7% +$70.7K 0.02% 797
2023
Q4 		$949K Sell
25,620
-2,955
-10% -$106K 0.02% 653
2023
Q3 		$1.04M Buy
28,575
+444
+2% +$15.8K 0.03% 527
2023
Q2 		$1M Buy
28,131
+2,252
+9% +$80.8K 0.03% 535
2023
Q1 		$921K Buy
25,879
+1,892
+8% +$66.2K 0.03% 525
2022
Q4 		$843K Buy
23,987
+1,742
+8% +$58K 0.03% 500
2022
Q3 		$655K Buy
22,245
+13,264
+148% +$503K 0.03% 481
2022
Q2 		$489K Buy
+8,981
New +$496K 0.02% 613

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tidal Investments's GSK Position: Q1 2026 in Review

Tidal Investments increased its GSK (GSK) stake by 336% in Q1 2026, buying an estimated $8.8M and bringing the position to 210,633 shares worth $11.5M. The position accounts for 0.02% of the portfolio, ranked #516.

Tidal Investments first reported a position in GSK in Q2 2022 and has held it in 16 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Tidal Investments held 210,633 shares of GSK worth $11.5M as of Q1 2026.
  • Tidal Investments bought 162,332 GSK shares in Q1 2026, an estimated $8.8M.
  • GSK made up 0.02% of Tidal Investments's portfolio in Q1 2026, its #516 holding.
  • Tidal Investments first reported a position in GSK in Q2 2022 and has held it in 16 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.